Atlas Trials

Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease

Clinical trial NCT00176475 · TERMINATED

Trial details

NCT number
NCT00176475
Sponsor
University of Medicine and Dentistry of New Jersey
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Start date
2005-01-01
Primary completion
2008-02-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.